Celgene & the Multiple Sclerosis Association of America Take the MS MindShift Initiative & “Brain Bulb” Hot Air Balloon t...
October 16 2019 - 6:00AM
Business Wire
Wheelchair Accessible Balloon Lifts Off at
Atlanta Area Festival
The MS MindShift: A New View of MS initiative from Celgene
Corporation (NASDAQ: CELG) and the Multiple Sclerosis Association
of America (MSAA) is making its third stop at the Owl-O-Ween Hot
Air Balloon Festival in Kennesaw, Ga., on October 18 and 19. At the
festival, the MS MindShift “Brain Bulb” hot air balloon will take
flight to raise awareness of multiple sclerosis (MS) and the
importance of brain health for those living with the condition.
MS MindShift is a national initiative which aims to educate
about the critical role the brain plays in the disease and what
people living with MS can do to help keep their brain as healthy as
possible, for as long as possible.
The MS MindShift Brain Bulb hot air balloon will be featured at
Owl-O-Ween as a way to literally elevate the importance of having a
“brain first” perspective in MS. Just as keeping a balloon in good
condition keeps it soaring above the ground, shifting focus up
toward the brain today could help change how people with MS live
with the disease tomorrow.
The Owl-O-Ween Hot Air Balloon Festival is metro Atlanta’s
largest hot air balloon festival and costume party. The MS
MindShift experience at this event will give attendees the
opportunity to learn more about the campaign first hand, encounter
the Brain Bulb balloon up close, and take a lift in the tethered
hot air balloon while gaining a new perspective on MS.
MS is a chronic and often debilitating disease that affects
nearly 1 million people in the U.S. In MS, the immune system
attacks the central nervous system – which includes the spinal cord
and brain. Localized injury to the brain produces “lesions” which
disrupt the flow of information from the brain to the body which
may lead to symptoms and relapses.
“Brain lesions can cause damaged areas of the brain to not
function properly. However, through an amazing process known as
neurological reserve, other areas of the brain can step in and
perform the tasks that part of the brain no longer can,” said Mitzi
Joi Williams, M.D., a neurologist at Joi Life Wellness Group. “It’s
important that people living with MS understand the role the brain
plays in the disease, as well as the healthy choices they can
consider to help maintain neurological reserve longer. This can
potentially help keep them from experiencing MS symptoms early on
in the disease.”
“We’re excited to partner with Celgene on the MS MindShift
campaign to raise awareness of this critical topic within the MS
community,” said Amanda Montague, Vice President of Education and
Healthcare Relations, MSAA. “This initiative aligns with our
mission to help improve the lives of people with MS by providing
them with the resources and support needed to help manage their
condition.”
“The MS MindShift initiative is an example of Celgene’s
commitment to the MS community and to supporting those living with
the condition by providing education and resources,” said Sheri
Lydick, US Commercial Lead, Celgene. “Events like the Owl-O-Ween
Hot Air Balloon Festival provide an opportunity to raise awareness
about MS among a broader audience and elevate this important
conversation.”
People with MS and those who support them can learn more about
the campaign at MSMindShift.com, and join the online community on
Facebook for more information about the MS MindShift events.
About Celgene
Celgene Corporation, headquartered in Summit, New Jersey, is an
integrated global biopharmaceutical company engaged primarily in
the discovery, development and commercialization of innovative
therapies for the treatment of cancer and inflammatory diseases
through next-generation solutions in protein homeostasis,
immuno-oncology, epigenetics, immunology and neuro-inflammation.
For more information, please visit www.celgene.com. Follow Celgene
on Social Media: @Celgene, Pinterest, LinkedIn, Facebook and
YouTube.
Forward-Looking Statements
This press release contains forward-looking statements, which
are generally statements that are not historical facts.
Forward-looking statements can be identified by the words
"expects," "anticipates," "believes," "intends," "estimates,"
"plans," "will," "outlook" and similar expressions. Forward-looking
statements are based on management's current plans, estimates,
assumptions and projections, and speak only as of the date they are
made. We undertake no obligation to update any forward-looking
statement in light of new information or future events, except as
otherwise required by law. Forward-looking statements involve
inherent risks and uncertainties, most of which are difficult to
predict and are generally beyond our control. Actual results or
outcomes may differ materially from those implied by the
forward-looking statements as a result of the impact of a number of
factors, many of which are discussed in more detail in our Annual
Report on Form 10-K and our other reports filed with the U.S.
Securities and Exchange Commission, including factors related to
the proposed transaction between Bristol-Myers Squibb and Celgene,
such as, but not limited to, the risks that: management’s time and
attention is diverted on transaction related issues; disruption
from the transaction make it more difficult to maintain business,
contractual and operational relationships; legal proceedings are
instituted against Bristol-Myers Squibb, Celgene or the combined
company that could delay or prevent the proposed transaction; and
Bristol-Myers Squibb, Celgene or the combined company is unable to
retain key personnel.
Hyperlinks are provided as a convenience and for informational
purposes only. Celgene bears no responsibility for the security or
content of external websites.
All trademarks are the property of their respective owners.
© 2019 Celgene Corporation 10/19 US-CLG-19-1441
###
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191016005089/en/
For inquiries, please contact: Celgene Corporation
Investors: Nina Goworek Executive Director, Investor Relations
908-673-9711
Media: Catherine Cantone Senior Director, Corporate
Communications 908-897-4256
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Aug 2024 to Sep 2024
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Sep 2023 to Sep 2024